ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response.
Holmes, Jacinta A
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response. [electronic resource] - Hepatology (Baltimore, Md.) Jun 2014 - 2152-60 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1527-3350
10.1002/hep.27022 doi
Adult
Anemia, Hemolytic--chemically induced
Antiviral Agents--administration & dosage
Clinical Trials, Phase IV as Topic
Drug Therapy, Combination
Female
Hepatitis C--complications
Humans
Interferon-alpha--administration & dosage
Male
Middle Aged
Polyethylene Glycols--administration & dosage
Pyrophosphatases--deficiency
Randomized Controlled Trials as Topic
Recombinant Proteins--administration & dosage
Retrospective Studies
Ribavirin--administration & dosage
Inosine Triphosphatase
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response. [electronic resource] - Hepatology (Baltimore, Md.) Jun 2014 - 2152-60 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1527-3350
10.1002/hep.27022 doi
Adult
Anemia, Hemolytic--chemically induced
Antiviral Agents--administration & dosage
Clinical Trials, Phase IV as Topic
Drug Therapy, Combination
Female
Hepatitis C--complications
Humans
Interferon-alpha--administration & dosage
Male
Middle Aged
Polyethylene Glycols--administration & dosage
Pyrophosphatases--deficiency
Randomized Controlled Trials as Topic
Recombinant Proteins--administration & dosage
Retrospective Studies
Ribavirin--administration & dosage
Inosine Triphosphatase